Purpose Early postoperative heart failure is common after cardiac surgery, and inotrope
treatment may impact renal perfusion and oxygenation. We aimed to study the renal effects …

Background and aim Inotropes are commonly used to treat myocardial dysfunction, which is
the major complication after coronary artery bypass graft (CABG). Milrinone, a …

OBJECTIVE: The long-term use of milrinone is associated with increased mortality in chronic
heart failure. A recent meta-analysis suggested that it might increase mortality in patients …

Background: The dose of milrinone should be reduced in patients with renal failure.
However, there is little data examining the relationship between plasma concentration of …

Objective: To compare the hemodynamic effects of milrinone during weaning from
cardiopulmonary bypass (CPB) in patients with a low pre-CPB cardiac index (CI)< 2.5 …

Purpose: In our study, it was aimed to investigate the preventive effect of milrinone on renal
damage in experimental controlled non-heart-beating donors (NHBDs) model. Materials and …

Although milrinone effectively increases cardiac function, few studies have specifically
evaluated its efficacy during cardiac surgery. We investigated the effects of milrinone on …

Objective: Phosphodiesterase inhibitor is essential to the pharmacologic management of
decompensated heart failure because it increases contractility and decreases afterload of …

Objective To evaluate intratracheal milrinone (tMil) administration for rapid treatment of right
ventricular (RV) dysfunction as a novel route after cardiopulmonary bypass. Design …

OBJECTIVE:: To compare the hemodynamic effects, pharmacokinetic profiles, and the need
for vasoactive agents between a low (20 μg/kg during 15 minutes [group 1; n= 10]) and a …